Welcome to HealthyDogPetCo Blog

Sitemap xml

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R. . Bautista-Hernández I, et al. Molecules. 2021 Aug 25;26(17):5156. doi: 10.3390/molecules26175156. Molecules. 2021. PMID: 34500592 . Am J Ther. 2021 Sep-Oct 01;28(5):e579-e580. doi: 10.1097/MJT.0000000000001443. Am J Ther. 2021. PMID: 34491955 Free PMC article. .
Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing.
Xu X, Chemparathy A, Zeng L, Kempton HR, Shang S, Nakamura M, Qi LS. Xu X, et al. .
Blood freezing to nearly absolute zero temperature: -272.29 degrees C.
Cravalho EG, Huggins CE, Diller KR, Watson WW. Cravalho EG, et al. . Free PMC article.
.
Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
Ashraf S, Ashraf S, Farooq I, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Akmal R, Ghufran M, Rafique S, Akram MK, Habib Z, Siddiqui UN, Ahmad A, Arshad S, Virk MAR, Gul M, Awais AB, Hassan M, Sherazi SSH, Safdar Z, Munir I, Khalid H, Munir K, Majeed N, Alahmadi YM, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE Consortium.

top
top
Page
Menu
News
top
Page
Menu
News
Home Print viewSitemap
 
top
Page
Menu
News